Solid Biosciences Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Solid Biosciences's estimated annual revenue is currently $12.4M per year.
- Solid Biosciences received $133.7M in venture funding in February 2018.
- Solid Biosciences's estimated revenue per employee is $120,388
- Solid Biosciences's total funding is $366.3M.
- Solid Biosciences has 103 Employees.
- Solid Biosciences grew their employee count by -34% last year.
- Solid Biosciences currently has 1 job openings.
What Is Solid Biosciences?
Solid Biosciences (Solid) is a Cambridge, MA based biotech company singularly focused on developing treatments and cures for Duchenne muscular dystrophy (DMD). Solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. Condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of DMD.keywords:Biotechnology,Healthcare,Pharmaceuticals